1
/
of
0
FDA Drug Approval, N217785, REZDIFFRA
FDA Drug Approval, N217785, REZDIFFRA
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 217785
Company: MADRIGAL
Drug Name: REZDIFFRA
Active Ingredients: RESMETIROM
Strength: 100MG
Dosage Form/Route: TABLET;ORAL
Action Date: 03/14/2024
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Company: MADRIGAL
Drug Name: REZDIFFRA
Active Ingredients: RESMETIROM
Strength: 100MG
Dosage Form/Route: TABLET;ORAL
Action Date: 03/14/2024
Marketing Status: Prescription
Submission Classification: Type 1 - New Molecular Entity
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details